Envestnet Asset Management’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-10,695
| Closed | -$164K | – | 4160 |
|
|
2023
Q2 | $164K | Buy |
10,695
+734
| +7% | +$11.3K | ﹤0.01% | 3756 |
|
|
2023
Q1 | $224K | Buy |
+9,961
| New | +$224K | ﹤0.01% | 3602 |
|
|
2022
Q4 | – | Sell |
-10,025
| Closed | -$247K | – | 4068 |
|
|
2022
Q3 | $247K | Buy |
10,025
+136
| +1% | +$3.35K | ﹤0.01% | 3477 |
|
|
2022
Q2 | $240K | Sell |
9,889
-473
| -5% | -$11.5K | ﹤0.01% | 3483 |
|
|
2022
Q1 | $267K | Buy |
10,362
+1,224
| +13% | +$31.5K | ﹤0.01% | 3515 |
|
|
2021
Q4 | $284K | Buy |
9,138
+171
| +2% | +$5.32K | ﹤0.01% | 3454 |
|
|
2021
Q3 | $217K | Buy |
+8,967
| New | +$217K | ﹤0.01% | 3466 |
|
|
2020
Q2 | – | Sell |
-17,061
| Closed | -$249K | – | 3176 |
|
|
2020
Q1 | $249K | Sell |
17,061
-4,889
| -22% | -$71.4K | ﹤0.01% | 2636 |
|
|
2019
Q4 | $312K | Buy |
21,950
+1,781
| +9% | +$25.3K | ﹤0.01% | 2713 |
|
|
2019
Q3 | $234K | Buy |
20,169
+1,471
| +8% | +$17.1K | ﹤0.01% | 2794 |
|
|
2019
Q2 | $376K | Buy |
18,698
+592
| +3% | +$11.9K | ﹤0.01% | 2532 |
|
|
2019
Q1 | $410K | Buy |
+18,106
| New | +$410K | ﹤0.01% | 2461 |
|
|
2017
Q3 | – | Sell |
-127
| Closed | -$2K | – | 3037 |
|
|
2017
Q2 | $2K | Sell |
127
-9
| -7% | -$142 | ﹤0.01% | 2959 |
|
|
2017
Q1 | $3K | Buy |
136
+5
| +4% | +$110 | ﹤0.01% | 2977 |
|
|
2016
Q4 | $2K | Buy |
+131
| New | +$2K | ﹤0.01% | 2996 |
|